Patents for A61P 19 - Drugs for skeletal disorders (81,981)
04/2013
04/03/2013CN103006898A Chinese medicament formula for treating osteoporosis
04/03/2013CN103006894A Camphor rheumatism agent
04/03/2013CN103006884A Chinese medicinal composition for treating osteoarthritis and preparation method thereof
04/03/2013CN103006882A Traditional Chinese medicine for treating ONFH (osteonecrosis of femoral head)
04/03/2013CN103006880A Preparation method of kidney tonifying and bone strengthening pill used for preventing and treating osteoporosis
04/03/2013CN103006865A External medicament composition for treating arthritis
04/03/2013CN103006861A External-use medicine for treating neck, shoulder, waist and leg diseases and osteoproliferation, and preparation method of medicine
04/03/2013CN103006857A Medicinal composition for treating scapulohumeral periarthritis
04/03/2013CN103006853A Traditional Chinese medicine for treating osteoporosis
04/03/2013CN103006823A Bruise medicated wine and preparation method thereof
04/03/2013CN103006817A Arthritis bath medicinal powder
04/03/2013CN103006816A Formula of knee joint osteoarthritis treatment traditional Chinese medicine
04/03/2013CN103006815A Traditional Chinese medicine external use film agent for treating pain diseases caused by rheumatoid bone diseases, cervical muscle and lumbar muscle degeneration, and scapulohumeral periarthritis
04/03/2013CN103006782A Ficus auriculata extract and application thereof in preparation of medicine used for treating osteoporosis
04/03/2013CN103006774A Externally applied powder for treating wind, cold, dampness and heat
04/03/2013CN103006770A Chinese medicinal composition for treating rheumatism and rheumatoid
04/03/2013CN103006763A Medicinal egg for treating arthritis and preparation method thereof
04/03/2013CN103006755A Beggarweed extractive and general flavone and rhizoma kaempferiae glycosides separated from the beggarweed extractive and medical application thereof
04/03/2013CN103006747A Application of ethyl acetate extract of celastrus orbiculatus stems in preparation of medicines for treating rheumatoid arthritis
04/03/2013CN103006737A Oral liquid used for promoting blood circulation to remove meridian obstruction and preventing and treating osteoporosis
04/03/2013CN103006732A Pharmaceutical composition for preventing ONFH (Osteonecrosis of Femoral Head) after child DDH (Developmental Dysplasia of Hip) operation
04/03/2013CN103006712A Bee product extract with functions of resisting oxidation and eliminating free radicals
04/03/2013CN103006693A Double-vitamin calcium carbonate composition
04/03/2013CN103006645A Application of 2-aminobenzothiazole derivatives being taken as DHODH (dihydroorotate dehydrogenase) inhibitor
04/03/2013CN103006570A Arzoxifene immediate-release pellets and preparation method thereof
04/03/2013CN103006544A Preparation method of high-viscoelasticity sodium hyaluronate gel
04/03/2013CN103006538A Ultrasonic microbubbles for treating arthritis and use thereof
04/03/2013CN103006428A Ointment healthcare appliance and manufacturing method thereof
04/03/2013CN102626382B Method for preparing sinomenine hydrochloride infusion solution and freeze-dried powder injection
04/03/2013CN102416153B Medicament for treating rheumatic arthritis
04/03/2013CN102363037B Externally applied plaster for treating rheumatism, rheumatoid arthritis and neck-shoulder and lumbocrural pain
04/03/2013CN102343066B Medicinal composition for treating hyperosteogeny and preparation method thereof
04/03/2013CN102343008B Chinese medicinal composition for treating prolapse of lumbar intervertebral disc
04/03/2013CN102302585B Chinese medicinal composition for treating arthralgia syndrome
04/03/2013CN102293977B Chinese medicinal composition for treating Bi syndrome, and preparation method and detection method of Chinese medicinal composition
04/03/2013CN102266409B Medicinal composition for treating pain and preparation method thereof
04/03/2013CN102258762B Medicinal composition for diminishing swelling and relieving pain and preparation and use thereof
04/03/2013CN102258633B Negundo chastetree fruit extract and application thereof
04/03/2013CN102247423B External-use Chinese herbal medicine compound preparation for accelerating fracture healing
04/03/2013CN102218095B Processing method of myrobalan-processed kusnezoff monkshood root as mongolian medicine
04/03/2013CN102172356B Use of taurochenodeoxycholic acid in prevention and treatment of osteoporosis
04/03/2013CN102134225B Tricyclic diterpene lactone and preparation method and application thereof
04/03/2013CN102086195B Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof
04/03/2013CN102048893B Traditional Chinese medicine composition for treating arthromyodynia
04/03/2013CN101878029B Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases
04/03/2013CN101857594B Tetrahydropyridoindole compounds, and preparation method and application thereof
04/03/2013CN101759656B Febuxostat new crystal forms and preparation method thereof
04/03/2013CN101631555B Prophylactic agent for autoimmune disease
04/03/2013CN101417059B Ointment for treating burn and scald and preparation method thereof
04/03/2013CN101374838B 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin K and S inhibitors
04/02/2013US8410174 Method for treating arthritis
04/02/2013US8410135 4,5 dihydro-(1H)-pyrazole derivatives as cannabinoid CB1 receptor modulators
04/02/2013US8410059 CXCR4 antagonist and use thereof
04/02/2013US8410053 Methods for treating autoimmune disorders, and reagents related thereto
04/02/2013US8409578 Methods for treating bone loss with antibodies to OPGL
04/02/2013CA2581110C Peptides and apl-type derivatives of hsp60 and pharmaceutical compositions
04/02/2013CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
04/02/2013CA2532799C Human antibody molecules for il-13
04/02/2013CA2524603C Controlled release composition containing a strontium salt
04/02/2013CA2503557C Osteogenesis promotor containing .beta.-cryptoxanthin as the active ingredient
04/02/2013CA2472647C Mammal prolactin variants
04/02/2013CA2396212C Recombinant antibodies to human interleukin-1 beta
03/2013
03/29/2013CA2849336A1 Cyanomethylpyrazole carboxamides as janus kinase inhibitors
03/28/2013WO2013043840A1 Method for treating osteoporosis
03/28/2013WO2013043529A1 Bone morphogenetic protein pathway activation, compositions for ossification, and methods related thereto
03/28/2013WO2013042782A1 Condensed heterocyclic compound
03/28/2013WO2013041502A1 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
03/28/2013WO2013041119A1 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
03/28/2013WO2013040649A1 Therapeutics using adipose cells and cell secretions
03/28/2013WO2013016720A3 Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases
03/28/2013WO2012165900A3 Peptide bfp 4 for promoting bone formation or vasculogenesis, and application therefor
03/28/2013US20130079514 "omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells"
03/28/2013US20130079377 Aryl or N-heteroaryl Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands
03/28/2013US20130079373 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands
03/28/2013US20130079337 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof
03/28/2013US20130079317 Methods for treatment of diseases
03/28/2013US20130078312 Biodegradable Putty Compositions and Implant Devices, Methods, and Kits Relating to the Same
03/28/2013US20130078311 Composition for treating and/or preventing osteoporosis
03/28/2013US20130078280 Cyclosporine analogue mixtures and their use as immunomodulating agents
03/28/2013US20130078237 Cd27l antigen binding proteins
03/28/2013CA2849357A1 Acyclic cyanoethylpyrazoles as janus kinase inhibitors
03/28/2013CA2848512A1 Method for treating osteoporosis
03/28/2013CA2846369A1 N-[4-(1h-pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides and their use as pharmaceuticals
03/27/2013EP2572721A1 Pharmaceutical composition including an hif-2 inhibitor as an active ingredient for preventing or treating arthritis
03/27/2013EP2572719A1 Use of poloxamines as inducers of the osteogenic differentiation of mesenchymal cells
03/27/2013EP2571988A1 Compositions for use in treating or diagnosing bone disorders and/or cardiovascular disorders
03/27/2013EP2571881A1 Pyrrolopyrazine derivatives as syk and jak inhibitors
03/27/2013EP2571532A2 Il-1 binding proteins
03/27/2013CN202820613U Novel cervical vertebra medicine pillow
03/27/2013CN202819713U Medicine type half-circular kneepad
03/27/2013CN1964956B Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
03/27/2013CN1671391B Novel methods and compositions for alleviating pain
03/27/2013CN103003234A N-hydroxyformamide derivative and pharmaceutical containing same
03/27/2013CN103002892A Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients
03/27/2013CN103002886A Treatment of osteoporosis
03/27/2013CN102994349A Production process of health-care tonic wine
03/27/2013CN102994324A Fresh bamboo juice liquor and its production method
03/27/2013CN102993289A Scolopendra mutilans polypeptide toxin kappa-SLPTX-Ssm4a and gene and application thereof
03/27/2013CN102993277A Novel immunomodulatory protein, preparation method and application
03/27/2013CN102988984A Aqueous drug preparation of anti-TNF (tumor necrosis factor)-alpha human monoclonal antibody for strengthening stability
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 820